Snibe
received the CE certificate (List A) for MAGLUMI® HBsAg (CLIA) assay On March 11,
2022. It further proves the high reliability of the quality and performance of
Snibe products, as well as a verification of Snibe’s leading position in the
field of chemiluminescence.
Based on assessment of
sequences and bioinformatics analysis, we confirm that Snibe’s assays for
detection of the SARS-CoV-2 virus in the table below are effective in detecting
SARS-CoV-2 variants reported by WHO including B.1.1.529 (Omicron), B.1.1.7 (Alpha),
B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta),C.37
(Lambda), B.1.617.1 (Kappa), etc.
From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.
EuroMedlab Munich 2022, the largest
exhibition in the field of Clinical Chemistry and Laboratory Medicine in
Europe, which attracted more than 2000 participants, was held in ICM
International Congress Center from April 10 to 14, 2022.
From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.